We are live on ! Find out more
NNVC icon

NanoViricides

17 hedge funds and large institutions have $247K invested in NanoViricides in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

2.94% more ownership

Funds ownership: 0.2%3.13% (+2.9%)

53% less funds holding

Funds holding: 3617 (-19)

66% less capital invested

Capital invested by funds: $731K → $247K (-$484K)

90% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 21

Holders
17
Holders Change
-19
Holders Change %
-52.78%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
8
Reduced
1
Closed
21
Calls
Puts
Net Calls
Net Calls Change

NNVC Hedge Fund Activity: Q3 2019 in Review

17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2019, worth a combined $247K — down 66% from $731K a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of NNVC and 2 opened new positions — a net loss of 19 holders — while 1 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $17.6K. The largest seller was Geode Capital Management, exiting entirely with an estimated $42K sold.

  • 17 institutional investors held NanoViricides (NNVC) as of Q3 2019, down from 36 in Q2 2019.
  • Funds reported $247K of NanoViricides stock for Q3 2019, down 66% quarter-over-quarter.
  • 2 funds opened new NanoViricides positions in Q3 2019 and 21 closed out, a net change of -19 holders.
  • The largest NanoViricides buyer in Q3 2019 was Renaissance Technologies, an estimated $17.6K added.
  • The largest NanoViricides seller in Q3 2019 was Geode Capital Management, an estimated $42K sold.

Based on aggregated 13F filings for Q3 2019.